Clinical Trial Update: Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical study sponsored by NKGen Biotech is evaluating SNK01 in participants with moderate Alzheimer's disease, and the trial is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• SNK01

Snippet

Sponsor: NKGen Biotech, Inc. | Conditions: Moderate Alzheimer Disease | Phase 1, Phase 2 | Status: RECRUITING